ReviewEcancermedicalscience2023

Application of the ASCO value framework to evaluate the clinical and economic value of enzalutamide and apalutamide in the early stages of prostate cancer in Colombia.

Martín Romero et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.